One in three children who survive meningitis will suffer after-effects

August 24, 2012
One in three children who survive meningitis will suffer after-effects
Brain scan. Image: Reigh LeBlanc/Flickr

(Medical Xpress)—New research published online first in The Lancet Neurology highlights the long-term, often hidden, after-effects of meningitis in children. The study, led by Professor Russell Viner at the UCL Institute of Child Health, shows that 1 in 3 children who have experienced meningococcal group B disease (MenB), the most common type of bacterial meningitis in the UK, will be left with after-effects.

and septicaemia affect around 3,400 people in the UK each year, and approximately half (1,700) of these are children. The new research, commissioned by national charity the Meningitis Trust, looked at the cognitive and psychological burden of MenB, as well as the major physical and neurological disabilities in children as young as three years old.

Victims were found to be significantly more likely to experience with one in five suffering anxiety or behavioural disorders. In addition, meningitis was found to impact on an individual's memory - both long and short term - and leave survivors significantly more likely to experience epilepsy.

The study also identified potential learning problems. Child victims can be left with a borderline low IQ, leaving them behind in the classroom and potentially limiting their . They are five times more likely to have speech and , and in later school life display poor executive function; affecting their ability to plan and organise, especially as they move from primary to secondary school.

Alongside the 'hidden' after-effects, the devastating physical impact of meningitis was also reported, with sufferers being five times more likely to have a significant , with 2.4% of survivors having bilateral hearing loss requiring a cochlear implant. In addition, significant with disability was witnessed.

Lead researcher, Professor Russell Viner at the UCL Institute of Child Health, said: "MOSAIC is the first comprehensive study of the outcomes of serogroup B meningococcal disease published anywhere in the world. It is also the largest study of the outcomes of meningococcal disease ever published. The high quality and importance of the data have been recognised by acceptance for fast-track publication in the prestigious international journal, The . As governments all around the world begin the process of deciding whether to introduce new MenB vaccines, the MOSAIC data will play a central role in informing these decisions."

The findings also support the Meningitis Trust's on-going campaign to increase understanding of the disease and its after-effects. Meningitis Changes Futures was set up to highlight the real impact of meningitis, focussing on tackling educational difficulties. The Meningitis Trust has called for the automatic right for any child who has had meningitis to have timely and appropriate assessments throughout their educational life, picking up on any issues early on.

Sue Davie, Chief Executive of the Meningitis Trust said: "The hidden, yet devastating, after-effects of meningitis can often be dismissed. We hope that the new findings will encourage education and health professionals to recognise these, as well as the noticeable physical after-effects of meningitis, and push for children to receive the support they need and deserve.

"In addition, we hope that parents will feel more empowered by these findings. They need to be confident when advising professionals that their child might be suffering from the after-effects of meningitis in order to change perceptions, and ensure meningitis is fully investigated as a possible cause."

Explore further: Researchers say step closer to meningitis B vaccine

Related Stories

Researchers say step closer to meningitis B vaccine

May 7, 2012
Researchers said Monday they were a step closer to developing a vaccine against the type of meningitis that mostly affects Europe and North America and kills hundreds every year.

A new strategy for developing meningitis vaccines

May 24, 2012
Bacterial meningitis is an infection of the meninges, the protective membrane that covers the spinal cord and brain. Children, elderly patients and immunocompromised patients are at a higher risk for the development of severe ...

Recommended for you

Addressing superbug resistance with phage therapy

August 16, 2017
International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug ...

Can previous exposure to west Nile alter the course of Zika?

August 15, 2017
West Nile virus is no stranger to the U.S.-Mexico border; thousands of people in the region have contracted the mosquito-borne virus in the past. But could this previous exposure affect how intensely Zika sickens someone ...

Compounds in desert creosote bush could treat giardia and 'brain-eating' amoeba infections

August 15, 2017
Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego and the University of Colorado Anschutz Medical Campus have found that compounds produced by the creosote bush, a ...

New malaria analysis method reveals disease severity in minutes

August 11, 2017
Left untreated, malaria can progress from being mild to severe—and potentially fatal—in 24 hours. So researchers at the University of British Columbia developed a method to quickly and sensitively assess the progression ...

Drug trial shows promise for deadly neurological disorder

August 10, 2017
Results of a small clinical trial show promise for treating a rare neurodegenerative condition that typically kills those afflicted before they reach age 20. The disease, called Niemann-Pick type C (NPC), causes cholesterol ...

Test uses nanotechnology to quickly diagnose Zika virus

August 10, 2017
Washington University in St. Louis researchers have developed a test that quickly detects the presence of Zika virus in blood.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.